<scp>Anti‐BP180</scp> , pruritus, and thymus and activation‐regulated chemokines as surrogate markers for disease activity in bullous pemphigoid-Reference-Cited by-同舟云学术

Anti‐BP180 , pruritus, and thymus and activation‐regulated chemokines as surrogate markers for disease activity in bullous pemphigoid

Published:2022-07-28 Issue:12 Volume:36 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Wada S.¹,Komori T.¹^ORCID,de Jesus C.S.¹^ORCID,Nomura T.¹²^ORCID,Komura T.¹,Yonekura S.¹^ORCID,Shibuya R.¹^ORCID,Adachi E.¹^ORCID,Sakurai Y.³,Ishikawa M.⁴,Usui S.¹,Kambe N.¹^ORCID,Kabashima K.¹^ORCID

Affiliation:

1. Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan

2. Department of Drug Discovery for Intractable Diseases Kyoto University Graduate School of Medicine Kyoto Japan

3. Department of Dermatology Saiseikai Noe Hospital Osaka Japan

4. Department of Dermatology Kyoto Katsura Hospital Kyoto Japan

Funder

Takeda Science Foundation

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18449

Reference7 articles.

1. Pemphigoid diseases

2. The pathogeneses of pemphigus and pemphigoid diseases

3. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid*

4. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid

5. Serum thymus and activation‐regulated chemokine (TARC/CCL17) may be useful to predict the disease activity in patients with bullous pemphigoid

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TARC/CCL17 reflects the severity of pemphigus (pemphigus vulgaris and pemphigus foliaceus) at the initial presentation;JEADV Clinical Practice;2024-03-11

2. Serum thymus and activation‐regulated chemokine is a surrogate marker for bullous pemphigoid disease activity;Journal of the European Academy of Dermatology and Venereology;2023-05-22